ExodusPoint Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17,381
| Closed | -$359K | – | 1515 |
|
|
2023
Q3 | $359K | Buy |
+17,381
| New | +$359K | ﹤0.01% | 1317 |
|
|
2023
Q2 | – | Sell |
-24,907
| Closed | -$574K | – | 1837 |
|
|
2023
Q1 | $574K | Buy |
+24,907
| New | +$574K | ﹤0.01% | 1206 |
|
|
2022
Q4 | – | Sell |
-23,434
| Closed | -$719K | – | 1678 |
|
|
2022
Q3 | $719K | Sell |
23,434
-40,753
| -63% | -$1.25M | 0.01% | 1209 |
|
|
2022
Q2 | $1.89M | Buy |
+64,187
| New | +$1.89M | 0.02% | 756 |
|
|
2021
Q3 | – | Sell |
-20,959
| Closed | -$1.64M | – | 2163 |
|
|
2021
Q2 | $1.64M | Buy |
+20,959
| New | +$1.64M | 0.02% | 714 |
|
|
2020
Q4 | – | Sell |
-5,723
| Closed | -$205K | – | 1965 |
|
|
2020
Q3 | $205K | Sell |
5,723
-9,914
| -63% | -$355K | ﹤0.01% | 1409 |
|
|
2020
Q2 | $378K | Buy |
+15,637
| New | +$378K | 0.01% | 1180 |
|
|
2019
Q4 | – | Sell |
-10,000
| Closed | -$153K | – | 1549 |
|
|
2019
Q3 | $153K | Buy |
+10,000
| New | +$153K | 0.01% | 1150 |
|
|
2019
Q2 | – | Sell |
-13,770
| Closed | -$320K | – | 1124 |
|
|
2019
Q1 | $320K | Buy |
+13,770
| New | +$320K | 0.02% | 443 |
|